Actionnariat et activité des initiés pour Terns Pharmaceuticals, Inc. (TERN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $52.95 |
| Capitalisation | $4.8B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-05-05 | Azelby Robert | D-Return | 90,000 | $372K |
| 2026-05-05 | Azelby Robert | D-Return | 1,697 | $59K |
| 2026-05-05 | Turner Heather D | D-Return | 45,000 | $184K |
| 2026-05-05 | Turner Heather D | D-Return | 64,000 | $365K |
| 2026-05-05 | Turner Heather D | D-Return | 1,697 | $59K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 64,000 | $136K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 45,000 | $184K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 10,657 | $48K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 4,676 | $32K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 32,000 | $224K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $82.5M | $12.3M | $74.9M | $47.7M | $143.2M | $79.9M | $161.4M | $524.7M |
| Placements à Court Terme | $4.4M | $7.3M | 0 | $118.3M | $139.9M | $183.5M | $196.7M | $494.2M |
| Créances | 0 | 0 | $12.7M | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $88.5M | $22.2M | $90.9M | $166.9M | $285.2M | $267.4M | $362.1M | $1.02B |
| Immobilisations Corporelles | $261000 | $961000 | $1.2M | $1.0M | $1.8M | $1.0M | $1.5M | $884000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $89.1M | $23.9M | $92.3M | $168.1M | $287.0M | $268.5M | $363.9M | $1.03B |
| Dettes Fournisseurs | $914000 | $1.6M | $935000 | $2.1M | $1.6M | $2.5M | $2.1M | $1.7M |
| Dette à Court Terme | 0 | 0 | $12.9M | 0 | 0 | 0 | $428000 | 0 |
| Passifs Courants | $2.4M | $5.0M | $22.8M | $6.8M | $8.5M | $11.9M | $15.7M | $16.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $16.8M | $5.6M | $23.7M | $7.8M | $10.1M | $13.2M | $18.1M | $18.6M |
| Réserves | -$23.3M | -$91.9M | -$131.9M | -$182.1M | -$242.4M | -$332.6M | -$421.5M | -$517.7M |
| Capitaux Propres | $72.2M | $4.2M | $68.6M | $160.3M | $276.9M | $255.4M | $345.9M | $1.01B |
| Dette Totale | 0 | 0 | $12.9M | 0 | $1.2M | $603000 | $1.3M | $919000 |
| Dette Nette | -$86.9M | -$19.6M | -$62.0M | -$166.0M | -$281.9M | -$262.8M | -$356.8M | -$1.02B |
| Fonds de Roulement | $86.1M | $17.3M | $68.0M | $160.1M | $276.7M | $255.5M | $346.5M | $1.01B |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 62.41 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 121.84 |
Rentabilité
| Rentabilité des capitaux propres | -20.02% |
| Rentabilité du capital investi | -10.91% |
| Rentabilité des actifs | -9.39% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: AMLX · ELVN · IMTX · INBX · NKTR · ORIC · PGEN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de TERN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions